Lantheus Holdings, Inc. Impairment of Long-Lived Assets to be Disposed of
Lantheus Holdings, Inc. (LNTH) reported Impairment of Long-Lived Assets to be Disposed of of $6.41 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2016-03-02
- Lantheus Holdings, Inc. impairment of long-lived assets to be disposed of for fiscal 2013 was $6.41M.
| Period end | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|
| 2013-12-31 | $6.41M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |